Discontinued — last reported Q4 '23
Business Segments · Restructuring Charges
CarelonRx Segment — Restructuring Charges
This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ1 2023
Last reportedQ4 2023
Rolls up toRestructuring Charges
How to read this metric
High charges indicate significant operational disruption or strategic pivot, which may lead to future cost savings.
Detailed definition
These are the expenses recognized in the income statement during a specific period related to the reorganization or down...
Peer comparison
Comparable to 'Restructuring and impairment charges' reported by other large healthcare service providers.
Metric ID:
elv_segment_carelonrx_segment_restructuring_chargesHistorical Data
1 years
| FY'23 | |
|---|---|
| Value | $0.00 |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Elevance Health's carelonrx segment — restructuring charges?
- Elevance Health (ELV) reported carelonrx segment — restructuring charges of $0.00 in Q4 2023.
- What does carelonrx segment — restructuring charges mean?
- The immediate financial cost of reorganizing the pharmacy services business.